The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40% of the ...
Do you think you're going to be the one dumb, ugly, tired person?' Inside a San Francisco startup's quest for peptide ...
One firm plans to make a semaglutide jab at a starting price of 1,290 rupees a month Read more at The Business Times.
After losing more than 100 pounds following gastric surgery, he tried Ozempic for a while, but the side effects were too much ...
Novo’s Wegovy pen starts at about 10,480 rupees in India and about $199 in the U.S. You can save this article by registering for free here. Or sign-in if you have an account. Indian drugmakers seized ...
Indian drugmakers seized on the patent expiry for Novo Nordisk A/S's blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest ...
It works by mimicking a hormone called GLP-1 that slows digestion and tells the brain you’re full. Ozempic has been proven to reduce cardiovascular risks like stroke or heart attack. As a prescription ...
Thousands of 'chubby' people join innovative scheme which offers ox innards, tongue, tail; officials warn over 'unhealthy' slimming methods ...
Investing.com -- Eli Lilly and Company (NYSE: LLY) is deepening its footprint in the world’s second-largest economy, with Chinese Commerce Minister Wang Wentao expressing hope that the pharmaceutical ...
A deluge of weight loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired on ...
Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it vulnerable to ...
Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results